• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524558
INE794A01010
1453.5908993
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NEULANDLAB
60.7
22038.54
EPS(TTM)
Face Value()
Div & Yield %
283.01
10
0.2
 
( Cr)
ParticularsMar 2026 ( Cr)Dec 2025 ( Cr)Sep 2025 ( Cr)
Gross Sales11.2712.7012.64
Other Operating Income0.000.000.00
Other Income 0.020.000.53
Total Income11.3012.7113.17
Total Expenditure 11.6511.9912.72
PBIDT-0.350.720.45
Interest 0.120.150.15
PBDT-0.470.570.30
Depreciation0.690.710.71
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.200.03-0.10
Reported Profit After Tax-0.96-0.17-0.31
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-0.96-0.17-0.31
EPS (Unit Curr.)-1.63-0.29-0.53
EPS (Adj) (Unit Curr.)-1.63-0.29-0.53
Calculated EPS (Unit Curr.)-1.63-0.29-0.53
Calculated EPS (Adj) (Unit Curr.)-1.63-0.29-0.53
Calculated EPS (Ann.) (Unit Curr.)-6.53-1.17-2.11
Calculated EPS (Adj) (Ann.) (Unit Curr.)-6.53-1.17-2.11
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity5.905.905.90
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)-3.115.673.56
PBDTM(%)-4.174.492.37
PATM(%)-8.52-1.34-2.45